Skip to main content
ToolsForensic Analysisinnovata pharmaceuticals

innovata pharmaceuticals

Supplier Forensic Analysis · Scanned: 2026/04/06

Disclaimer: Statistical patterns flagged for review only. This tool does not determine or imply wrongdoing. All findings require independent verification.
Risk Score
0RISK SCORE
LOW RISK
Compliance
N/A/100
Awards
3
Total Value
R 2,2B

Recent Awards

3 awards · Total: R 2 158 224 554

Showing 5 of 3
HP02-2025AI: Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2025 to 30 September 2028.
Health
Ref: HP02-2025AI
R 399 138 654
21 Aug 2025
HP13-2025ARV: Supply and Delivery of Anti-Retroviral Medicines to the Department of Health for the period 1 July 2025 to 30 June 2028
Health
Ref: HP13-2025ARV
R 1 574 945 706
20 Aug 2025
Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2023 to 30 September 2025
Health
Ref: HP02-2023AI
R 184 140 195
15 Jun 2023

Risk Assessment

0RISK SCORE
LOW RISK

Based on 0 forensic flags detected

Unlock Full Analysis

Get access to all forensic flags, evidence details, and AI-generated audit narratives.

View Full Intelligence Report

Get complete award history, director network, and compliance analysis.

View Report →